Mycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathy

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheu

(2017) Rohit Aggarwal et al.   Arthritis & Rheumatology

Multitarget Therapy for Induction Treatment of Lupus Nephritis

(2015) Zhihong Liu et al.   ANNALS OF INTERNAL MEDICINE

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets

(2015) Siamak Moghadam-Kia et al.   Expert Review of Clinical Immunology

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) -- Report from OMERACT CTD-ILD Working Group

(2015) D. Khanna et al.   JOURNAL OF RHEUMATOLOGY

Inflammatory Muscle Diseases

(2015) Marinos C. Dalakas   NEW ENGLAND JOURNAL OF MEDICINE

Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease

(2013) A. Fischer et al.   JOURNAL OF RHEUMATOLOGY

Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial

(2012) Chester V. Oddis et al.   ARTHRITIS AND RHEUMATISM

Juvenile Dermatomyositis: Immunopathogenesis, Role of Myositis-Specific Autoantibodies, and Review of Rituximab Use

(2011) Yvonne E. Chiu et al.   PEDIATRIC DERMATOLOGY

Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis

(2009) Maria Giovanna Danieli et al.   AUTOIMMUNITY REVIEWS

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis

(2008) M. O. Harris-Love et al.   RHEUMATOLOGY